Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules
Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report
In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show
NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies
Researcher Falsified EMF Data, ORI Says
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- How City of Hope is turning microbiome science into better cancer care
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.”









